EGFR testing: Best practice for NSCLC patients with exon 20 insertions

Share :
Published: 30 Mar 2022
Views: 3291
Dr Antonio Passaro, Dr Umberto Malapelle and Dr Joshua Sabari

Dr Antonio Passaro (European Institute of Oncology, Milan, Italy), Dr Umberto Malapelle (University of Naples Federico II, Naples, Italy) and Dr Joshua Sabari (NYU Langone Health, New York City, USA) discuss EGFR testing and the best practice for patients with Exon 20 insertions.

Initially, they discuss some treatment options for Exon 20 insertion mutation NSCLC patients. Dr Malapelle and Dr Passaro then talk about the different methodologies for EGFR Exon 20 insertions testing.

Dr Malapelle mentions which of these methodologies are the best to use and when to use liquid vs tissue biopsies. Dr Sabari talks about the recent research from ELCC that highlights the best treatment options for these patients.

This programme is supported by an unrestricted educational grant from Janssen.